← Leaderboards
Scott D Gray-Owen
University Of Calgary
$6,165,048
Attributed
$12,479,595
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2017–25$2.5M$1.9M$1.3M$625K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,479,595 · 6
By mechanism
R01$11,178,430 · 4
U19$1,301,165 · 2
Top collaborators
- Cynthia Nau Cornelissen7 shared
- Andrew Emili5 shared
- Trevor F Moraes5 shared
- Anthony Bernard Schryvers5 shared
Most similar at University Of Calgary
Same institution · by research overlap
- Anthony Bernard Schryvers$2,691,617
- Trevor F Moraes$2,364,345
Others in their field
Other Emerging Leaders on “Proteins”
- John Damon Chodera · Sloan-Kettering Inst Can Research$50,971,767
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$40,723,314
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
Research focus
ProteinsNeisseria GonorrhoeaeGonorrheaPathogenInfectionMouse ModelReproductive TractVariantSexually Transmitted DiseasesMucous MembraneBacteriaAnimal ModelTransgenic MiceAntigensImmunityPelvic Inflammatory DiseaseVaccinesHumanized MouseIronNutrientInnovationFemaleImmune ResponseTransferrin
Grant awards (21)
Mapping Protein Interaction Networks Essential for Gonococcal Pathogenesis$560,203
R01 · FY2025 · AI
Transgenic mouse models of disease to test an innovative OMV-based vaccine for protection against the pathogenic Neisseriae$379,021
R01 · FY2025 · AI
Transgenic mouse models of disease to test an innovative OMV-based vaccine for protection against the pathogenic Neisseriae$300,744
R01 · FY2025 · AI
Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance$1,017,518
R01 · FY2024 · AI
Mapping Protein Interaction Networks Essential for Gonococcal Pathogenesis$566,961
R01 · FY2024 · AI
Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance$602,472
R01 · FY2023 · AI
Mapping Protein Interaction Networks Essential for Gonococcal Pathogenesis$594,564
R01 · FY2023 · AI
Immunology Core$414,756
U19 · FY2023 · AI · contact PI
Mapping Protein Interaction Networks Essential for Gonococcal Pathogenesis$628,605
R01 · FY2022 · AI
Immunology Core$270,000
U19 · FY2022 · AI · contact PI
Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance$810,000
R01 · FY2021 · AI
Mapping Protein Interaction Networks Essential for Gonococcal Pathogenesis$662,861
R01 · FY2021 · AI
Rational design of transferrin binding protein-based vaccines to combat gonorrhea$627,981
R01 · FY2021 · AI
Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance$810,000
R01 · FY2020 · AI
Rational design of transferrin binding protein-based vaccines to combat gonorrhea$626,726
R01 · FY2020 · AI
Immunology Core$278,867
U19 · FY2020 · AI · contact PI
Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance$1,112,000
R01 · FY2019 · AI
Rational design of transferrin binding protein-based vaccines to combat gonorrhea$612,866
R01 · FY2019 · AI
Immunology Core$337,542
U19 · FY2019 · AI · contact PI
Rational design of transferrin binding protein-based vaccines to combat gonorrhea$613,296
R01 · FY2018 · AI
Rational design of transferrin binding protein-based vaccines to combat gonorrhea$652,612
R01 · FY2017 · AI